If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Wednesday, September 18, 2019 
Market Status: OPEN
About us and Governance Investor Relations Contact
Advanced search

Market News

Med Life S.A. - M

Announcement preliminary financial results 2018

Release Date: 2/18/2019 9:45:34 AM

IRIS Code: 82BEA


MedLife ends 2018 with 29% increase in Pro-Forma Sales and EBITDA higher by 33% as compared to prior year


February 18, 2019, Bucharest: MedLife, the leader of the private medical services market in Romania, announces the end of 2018 with Consolidated Pro-forma Sales of RON 804 million at group level, registering an increase of 29 % as compared to 2017. In terms of EBITDA, the Group achieved an increase of 33% as compared to the previous period, pro-forma EBITDA reported at the level of 2018 being RON 103 million.


In terms of pro-forma sales split by business lines, clinics and the corporate division have the largest share,  with 31% and 21% respectively, and it is also worth mentioning that the clinic segment had an increase of around 50% as compared to 2017. The ranking is followed by hospitals and labs with 20% and 17% share in pro-forma sales. According to the company's representatives, the results are in line with the initial estimates and significantly above the growth rate of the market.


"2018 was a challenging year, full of projects that focused on development through acquisitions. We have completed the Polisano transaction and brought to our group through acquisition of the majority stakes three other companies: Ghencea Medical Center, Solomed and Transilvania Imagistica, thus reaching a very good coverage of the country. At the same time, we have made an important step for a new stage of business digitization by adding to the group the largest medical information hub - sfatulmedicului.ro, "declared Mihai Marcu, President and CEO of MedLife Group.


Development projects continued on the organic development segment also. The group strengthened its position in the western part of Romania, inaugurating the first hyperclinic in Oradea. At the same time, in autumn last year, the second brand of the group, Sfanta Maria, was officially launched, the first clinic being opened in Bacau. "Sfanta Maria has become an important player on the medical services market in Romania, with an extensive network of general practitioners and specialists under contract with NHIH, providing patients with quality medical services and a wide range of analyzes. In 2019, this second MedLife brand will continue to grow, with a strategy to cover cities under 100,000 inhabitants so that regardless of income, Romanians will have access to quality medical services" said Mihai Marcu.


For 2019, MedLife group representatives want to maintain the dynamic pace of development. The company started the year by announcing the acquisition of the majority stake in Rozsakert Medical Center in Hungary, being the only Romanian operator of private medical services to expand abroad.


"From the listing on the Bucharest Stock Exchange, after a 2015 year in which we had a turnover of EUR 85 million, we were the first private medical company in Romania that exceeded the EUR 100 million threshold reaching EUR 176 million at the end of 2018. This, coupled with the acquisition of the Rozsakert majority stake in Hungary and the new openings, gives us the hope that we will be the first to exceed the threshold of EUR 200 million in 2019 ", concluded Mihai Marcu.



About MedLife:


MedLife is the largest private medical operator in Romania. The company operates the largest network of

clinics, one of the major networks of medical laboratories, multi and monodisciplinary hospitals and it has

the largest client base for Health Prevention Packages at national level. Also, sales-wise, it is one of the

major private healthcare companies in Central and Eastern Europe.


The stock issued by MedLife SA is accepted for trading on the spot regulated market, managed by the

Bucharest Stock Exchange, under the Premium Category, trading symbol “M”.


The MedLife Group has a successful background regarding both organic and also acquisition growth. Since 2009 the company has opened or bought over 83 medical units. Its strong and experienced management team has been able to create and manage these growth opportunities, acquiring valuable experiences and knowledge, allowing it to find the best way for carrying on the expansion process successfully.



Information provided by IRIS, the news platform of the Bucharest Stock Exchange.


Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

©2016 Bucharest Stock Exchange. All rights reserved